View in EDS

Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NéoVac Study).

Saved in:
Bibliographic Details
Title: Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NéoVac Study).
Authors: Gosset A; Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France., Diallo MY; Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France., Betsem E; Laboratoire Mixte International de Vaccinologie (LAMIVAC), Bobo-Dioulasso, Burkina Faso; Agence de Médecine Préventive (AMP), Bobo-Dioulasso, Burkina Faso., Schaeffer L; Unité d'Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France., Meda N; Centre Muraz, Bobo-Dioulasso, Burkina Faso., Vray M; Unité d'Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France., Sombie R; Département d'Hépato-gastroentérologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso., Shimakawa Y; Unité d'Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France. Electronic address: yusuke.shimakawa@gmail.com., Boyer S; Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France. Electronic address: sylvie.boyer@inserm.fr.
Source: Vaccine [Vaccine] 2021 Jul 30; Vol. 39 (33), pp. 4659-4670. Date of Electronic Publication: 2021 Jul 05.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2021.06.059